Fortress Biotech, Inc. Debt Instrument, Basis Spread on Variable Rate
Fortress Biotech, Inc. (FBIO) reported Debt Instrument, Basis Spread on Variable Rate of 0.75% for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 · last filed 2014-05-12
- Fortress Biotech, Inc. debt instrument, basis spread on variable rate for the quarter ending 2014-03-31 was 0.75%.
| Period end | Debt Instrument, Basis Spread on Variable Rate 3 month |
|---|---|
| 2014-03-31 | 0.75% 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |